What is a peptide terminal modification?
It is a chemical change or functional group intentionally introduced at the N-terminus, C-terminus, or both termini of a peptide to alter stability, charge, detection, conjugation, targeting, or other properties.
How do I choose between the N-terminus and C-terminus?
Choose the terminus least involved in biological recognition or activity, then consider synthetic accessibility, payload size, linker needs, and the intended downstream chemistry.
What code do you use for N-terminal acetylation?
Bio-Synthesis commonly uses [Ace] to denote N-terminal acetylation in peptide notation.
Is C-terminal amidation the same as attaching an amine linker?
No. C-terminal amidation converts the terminal carboxyl group to a carboxamide. A terminal amine linker introduces a separate reactive amine through a designed linker or residue.
Can fluorophores be placed at either terminus?
Often yes, but the synthetic route differs. N-terminal labeling can use the terminal amine directly, while C-terminal labeling usually requires a designed linker, functionalized residue, or post-synthetic conjugation handle.
When should a spacer be added?
A spacer is useful when a bulky label, biotin, chelator, lipid, or conjugation partner may be sterically hindered or may interfere with peptide binding. PEG, AEEA, Ahx, and beta-alanine are common options.
Can both termini be modified in one peptide?
Yes. Dual-terminal engineering can combine two compatible functions, provided the reaction sequence, protecting-group strategy, purification, and analytical confirmation are planned together.
Are terminal modifications always installed on-resin?
No. Stable, compact groups may be installed during solid-phase synthesis, while sensitive dyes, complex chelators, lipids, and other payloads may be better introduced post-synthetically.
How are terminal modifications confirmed?
Identity is typically confirmed by mass spectrometry and purity by analytical HPLC. Additional assays may be included for fluorophore performance, peptide content, amino acid composition, or other project-specific requirements.
What information should I provide for a feasibility review?
Provide the peptide sequence, intended application, desired terminus, modification or conjugation partner, linker preference, quantity, purity, formulation, and analytical requirements.